This work aims to design and identify inhibitors of human basigin to stop viral entry into the cell by developing an e-Pharmaco­phore model of receptor-ligand interaction between CD147 and various U.S. Food and Drug Administration (FDA)–approved drugs for COVID-19. The gene discussed is BSG; the disease is COVID-19.